Key result
Multiple primary OSCCs linked to ~29% lower 5-year overall survival versus single tumors.
Why the study?
The rising incidence of multiple primary cancers among patients with oral squamous cell carcinoma presents a profound clinical challenge.
Do patients with multiple primary oral squamous cell carcinomas have worse survival outcomes compared to those with single primary OSCC?
Cohort (n=1,909)
No
Do patients with multiple primary oral squamous cell carcinomas have worse survival outcomes compared to those with single primary OSCC?
Answers are grounded in this paper and cite their sources.
Patients with multiple primary oral squamous cell carcinomas have distinct clinical phenotypes and significantly poorer 5-year overall and progression-free survival compared to those with single primary tumors.
BACKGROUND: The rising incidence of multiple primary cancers among patients with oral squamous cell carcinoma (OSCC-MPCs) presents a profound clinical challenge. This study aimed to characterize the clinicopathological phenotypes and survival outcomes of OSCC-MPCs compared with those of single primary OSCC (SPOSCC), and to develop robust prognostic nomograms for the OSCC-MPCs population. METHODS: In this single-centre retrospective cohort study (2015-2025), clinicopathological and systemic inflammatory indices were extracted. Survival outcomes were compared using Kaplan-Meier analysis. Least Absolute Shrinkage and Selection Operator (LASSO) coupled with multivariable Cox regression were employed to identify independent predictors and construct nomograms for overall survival (OS) and progression-free survival (PFS). RESULTS: Among the 1,909 patients (OSCC-MPCs: n = 249; SPOSCC: n = 1,660), the OSCC-MPCs cohort exhibited an older age at diagnosis, lower rates of smoking and alcohol consumption, higher T but lower N categories, and significantly elevated preoperative neutrophil-to-lymphocyte ratios (NLR). Survival analysis based on complete survival data (OSCC-MPCs: n = 249; SPOSCC: n = 1,546) revealed significantly inferior outcomes in the OSCC-MPCs group compared with the SPOSCC group, demonstrating markedly reduced 5-year OS (51.28% vs. 79.85%, P < .001) and PFS (37.97% vs. 63.05%, P < .001) rates. LASSO-Cox regression identified age > 60 gt; 60 years, advanced T/N categories, NLR > 2.5, and specific treatment modalities as independent prognostic factors. The resulting dual-endpoint nomograms demonstrated reliable discrimination, optimal calibration, and substantial clinical net benefit. CONCLUSION: OSCC-MPCs exhibit highly distinct clinical phenotypes and are associated with significantly poorer survival compared with SPOSCC. Our nomograms, integrating clinicopathological features with NLR, provide robust, non-invasive quantitative tools to tailor individualized therapeutic interventions and optimize long-term surveillance strategies.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) conducted a cohort in Oral squamous cell carcinoma (n=1,909). Multiple primary cancers (OSCC-MPCs) vs. Single primary OSCC (SPOSCC) was evaluated on 5-year overall survival (p=< .001). Patients with multiple primary oral squamous cell carcinomas had lower 5-year overall survival compared to those with single primary tumors.
Synapse has enriched 10 related papers. Consider them for comparative context: